GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Other Long Term Assets

Philogen SpA (STU:78Q) Other Long Term Assets : €8.65 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Other Long Term Assets?

Philogen SpA's other long-term assets for the quarter that ended in Dec. 2024 was €8.65 Mil.

Philogen SpA's quarterly other long-term assets declined from Dec. 2023 (€2.91 Mil) to Jun. 2024 (€2.77 Mil) but then increased from Jun. 2024 (€2.77 Mil) to Dec. 2024 (€8.65 Mil).

Philogen SpA's annual other long-term assets declined from Dec. 2022 (€3.09 Mil) to Dec. 2023 (€2.91 Mil) but then increased from Dec. 2023 (€2.91 Mil) to Dec. 2024 (€8.65 Mil).


Philogen SpA Other Long Term Assets Historical Data

The historical data trend for Philogen SpA's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Other Long Term Assets Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
1.17 2.33 3.09 2.91 8.65

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.09 3.56 2.91 2.77 8.65

Philogen SpA Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Philogen SpA Business Description

Traded in Other Exchanges
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines